R
Rainer J. Klement
Researcher at University of Zurich
Publications - 141
Citations - 4144
Rainer J. Klement is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Stars. The author has an hindex of 30, co-authored 117 publications receiving 3405 citations. Previous affiliations of Rainer J. Klement include University of Würzburg & Max Planck Society.
Papers
More filters
Journal ArticleDOI
Identifying factors associated with COVID-19 related deaths during the first wave of the pandemic in Europe
Rainer J. Klement,Harald Walach +1 more
TL;DR: Adequate vitamin D levels are important, while flu-vaccination in the elderly and stronger government response were putative aggravating factors of COVID-19 related deaths, which may inform protection strategies against future infectious disease outbreaks.
Posted ContentDOI
Low Carb (LCD) and Ketogenic (KD) Diets Increase Quality of Life, Physical Performance, Body Composition and Metabolic Health of Women with Breast Cancer Better Than a Standard Diet (SD)
TL;DR: A well-defined KD and LCD are safe and beneficial for BC, and both diets could thus be recommended for patients wanting to self-support their rehabilitation process.
Journal ArticleDOI
Impact of a ketogenic diet intervention during radiotherapy on body composition: V. Final results of the KETOCOMP study for head and neck cancer patients
TL;DR: In this paper , the impact of a ketogenic diet (KD) versus an unspecified standard diet (SD) on body composition and survival in HNC patients undergoing radio(chemo)therapy was investigated.
Journal ArticleDOI
Fasten als Nebenwirkungsmanagement
TL;DR: In der Arbeit von Tanya Dor and Kollegen wurde nun über klinische Ergebnisse bei Krebspatienten berichtet, welche vor ihrer CHT eine Fastenperiode durchlaufen hatten.
Journal ArticleDOI
High-dose re-irradiation of intracranial lesions - Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation.
I. Stiefel,Christina Schröder,Christina Schröder,Stephanie Tanadini-Lang,I. Pytko,Erwin Vu,Rainer J. Klement,Matthias Guckenberger,N. Andratschke +8 more
TL;DR: In this paper, the authors analyzed dosimetric and clinical data of patients receiving cranial re-irradiation using EQD2 sum plans and concluded that repeated radiotherapy appears both safe and efficient in patients with recurrent primary or secondary brain tumors with doses to the brain up to 120 Gy 2 EQD 2, doses below 100 Gy 2 for brainstem and doses below 75 Gy 2 EQD 2 to chiasm and optic nerve.